NOVO — Oktober 2023
-
Novo Nordisk får lagt over 22 pct. til kursmålet hos Carnegie
30.10.2023 07.49 • MarketWire •
Novo Nordisks kursmål er blevet hævet til 785 kr. fra 642,50 kr. hos investeringsbanken Carnegie.Det fremgår af Bloomberg News.
Anbefalingen er uændret "køb".
Novo-aktien bakkede fredag 2,4 pct. til 660,20 kr.
.\˙ MarketWire
-
Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors? https://www.proinvestor.com/investornyt/1071604/ozempic-just-shrugged-off-a-challenge-from-viatris-what-does-this-mean-for-investors
-
The Ozempic Effect Is Coming for Everything From Kidney to Heart Disease Treatments
It could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s. https://www.bloomberg.com/news/features/2023-10-18/glp-1-drug-benefits-like-ozempic-go-beyond-weight-loss?utm_medium=cpc_social&utm_source=twitter&utm_campaign=BLOM_ENG_WEEKLYX_Y0469_TW_SO_WTRF_BROADXXXXX_KEYCO_00XXXXCPC_2PTW_XXXX_BUSFINLUXREAD_X1854_Y0469_XXXEN_TWITOA_OZEM_BW_EN_PG_NFLINKS&twclid=2-ga9fpxbfg0alvly9tknv
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind